Heidi Chen - Zoetis President

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 35px;;'>ZTS</div>
ZTS -- USA Stock  

Earning Report: February 13, 2020  

  President
Ms. Heidi C. Chen serves as Executive Vice President, General Counsel, Corporationrationrate Secretary of Zoetis Inc. Ms. Chen has served as our Executive Vice President and General Counsel since October 2012, and as our Corporationrationrate Secretary since July 2012. Prior to that, Ms. Chen was Vice President and Chief Counsel of Pfizer Animal Health, our predecessor company, from 2009 to 2012. Ms. Chen joined Pfizer in 1998 and held various legal and compliance positions of increasing responsibility, including lead counsel for Pfizers Established Products business.
Age: 51  President Since 2012      
973 822-7000  www.zoetis.com
Chen earned a Bachelor?s degree from Yale University and received a Juris Doctorate from Cornell Law School. She has participated in Columbia Business School?s Executive Education Program.

Heidi Chen Latest Insider Activity

Management Efficiency

The company has Return on Asset of 10.7 % which means that on every $100 spent on asset it made $10.7 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 0.01 % implying that it generated $0.01 on every 100 dollars invested.
The company has 6.66 B in debt with debt to equity (D/E) ratio of 248.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Ganadhish KamatDr Reddys Laboratories Ltd
2016
James DillardPerrigo Company Plc
2019
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Umang VohraDr Reddys Laboratories Ltd
2013
Svend AndersenPerrigo Company Plc
2017
Louis YuPerrigo Company Plc
2013
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Jeffrey NeedhamPerrigo Company Plc
2009
John HendricksonPerrigo Company Plc
2016
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Douglas BoothePerrigo Company Plc
2013
Jay MarkowitzRegeneron Pharmaceuticals
2017
Samiran DasDr Reddys Laboratories Ltd
2016
Amit BiswasDr Reddys Laboratories Ltd
2016
Michael StewartPerrigo Company Plc
2004
John WesolowskiPerrigo Company Plc
2016
K RaoDr Reddys Laboratories Ltd
2016
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Thomas FarringtonPerrigo Company Plc
2015
James MichaudPerrigo Company Plc
2016
Scott JamisonPerrigo Company Plc
2011

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Return On Equity0.0052
Return On Asset10.70
Profit Margin23.81
Operating Margin39.29
Current Valuation66.13 B
Shares Outstanding476.3 M
Shares Owned by Insiders0.07